Experiments for taxon Cudrania tricuspidata (MORACEAE)

166 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
728953	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIOXIDANT ACTIVITY	Cudrania tricuspidata (MORACEAE)
114468	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cudrania tricuspidata (MORACEAE)	CUDRAXANTHONE J
728947	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIOXIDANT ACTIVITY	Cudrania tricuspidata (MORACEAE)
1304864	PHARMACOLOGY OF COMPOUND - IN VITRO	NITRIC OXIDE RELEASE INHIBITION	Cudrania tricuspidata (MORACEAE)	FLAVONE,ISO: 5-4-DIHYDROXY-6-(3'-METHYLBUT-2"-ENYL)-2"-(4"-HYDROXY-4"METYLETHYL)-3"-METHOXYDIHYDROFURANO-[4',5",7,8]:
236311	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)	GERICUDRANIN B
747129	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Cudrania tricuspidata (MORACEAE)
490485	IDENTIFICATION IN BY HPLCQUANTITATIVE DATA		Cudrania tricuspidata (MORACEAE)	POPULNIN
181259	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)	GERICUDRANIN D
1073957	PLANT TISSUE CULTURE MARKER CODEREVIEW OF		Cudrania tricuspidata (MORACEAE)
236314	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)	GERICUDRANIN C
236303	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)	GERICUDRANIN A
785589	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTITUMOR ACTIVITY	Cudrania tricuspidata (MORACEAE)
236300	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cudrania tricuspidata (MORACEAE)	GERICUDRANIN A
181264	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)	CERICUDRANIN E
774698	PHARMACOLOGY OF EXTRACT - IN VIVO	HYPERTENSIVE ACTIVITY	Cudrania tricuspidata (MORACEAE)
114467	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cudrania tricuspidata (MORACEAE)	CUDRAXANTHONE I
820769	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)	Cudrania tricuspidata (MORACEAE)
738119	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)
1304870	PHARMACOLOGY OF COMPOUND - IN VITRO	NITRIC OXIDE RELEASE INHIBITION	Cudrania tricuspidata (MORACEAE)	GERICUDRANIN E
390148	ISOLATION AND IDENTIFICATION OF		Cudrania tricuspidata (MORACEAE)	KAEMPFEROLPOPULNIN
1296676	PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Cudrania tricuspidata (MORACEAE)	POLYSACCHARIDE CTPS-01
1055032	STRUCTURE DETERMINATION OFCORRECTION OF STRUCTURE		Cudrania tricuspidata (MORACEAE)	EUCHRESTAFLAVANONE C
122932	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cudrania tricuspidata (MORACEAE)	CUDRAXANTHONE M
236306	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cudrania tricuspidata (MORACEAE)	GERICUDRANIN B
236317	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)	GERICUDRANIN C
1304858	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cudrania tricuspidata (MORACEAE)	ERYSENEGALENSEIN E,ISO:
1057792	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cudrania tricuspidata (MORACEAE)	CUDRAXANTHONE A
561389	PHARMACOLOGY OF COMPOUND - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Cudrania tricuspidata (MORACEAE)	ARTHOCARPETIN,NOR:
1274418	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)	CUDRAXANTHONE LXANTHEN-9-ONE,9(H): 2-3-6-8-TETRAHYDROXY-1-(3-METHYL-BUT-2-ENYL)-5-(2-METHYL-BUT-3-EN-2-YL):MACLURAXANTHONE B
738114	VOUCHER SPECIMEN REPORTED FOR		Cudrania tricuspidata (MORACEAE)
561377	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Cudrania tricuspidata (MORACEAE)
561372	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Cudrania tricuspidata (MORACEAE)
1304867	PHARMACOLOGY OF COMPOUND - IN VITRO	NITRIC OXIDE RELEASE INHIBITION	Cudrania tricuspidata (MORACEAE)	ERYSENEGALENSEIN E,ISO:
124594	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORTLC DATA REPORTED		Cudrania tricuspidata (MORACEAE)	CUDRAXANTHONE E
597924	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Cudrania tricuspidata (MORACEAE)	POPULNINNARINGENIN-7-O-BETA-D-GLUCOSIDE
112042	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATATLC DATA REPORTEDISOLATION AND IDENTIFICATION OF		Cudrania tricuspidata (MORACEAE)	JACARUEBIN,ISO: 6-DEOXY:
926939	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cudrania tricuspidata (MORACEAE)	CUDRAFLAVONE A
561390	PHARMACOLOGY OF COMPOUND - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Cudrania tricuspidata (MORACEAE)	ARTHOCARPESIN
84552	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR		Cudrania tricuspidata (MORACEAE)	CUDRAFLAVANONE A
561384	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Cudrania tricuspidata (MORACEAE)
1304868	PHARMACOLOGY OF COMPOUND - IN VITRO	NITRIC OXIDE RELEASE INHIBITION	Cudrania tricuspidata (MORACEAE)	FLAVONE,ISO: 4'-5-7-TRIHYDROXY-6,8-PRENYL:
1304860	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cudrania tricuspidata (MORACEAE)	GERICUDRANIN D
926943	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cudrania tricuspidata (MORACEAE)	CUDRAFLAVONE C
395481	PLANT TISSUE CULTURE MARKER CODEISOLATION AND IDENTIFICATION OF		Cudrania tricuspidata (MORACEAE)	GERICUDRANIN BGERICUDRANIN A
561373	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Cudrania tricuspidata (MORACEAE)
1304850	MEDICINAL FOLKLORE REPORTED FOR	ANTIHEPATOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)
561388	PHARMACOLOGY OF COMPOUND - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Cudrania tricuspidata (MORACEAE)	POPULNIN
561383	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Cudrania tricuspidata (MORACEAE)
728946	PHARMACOLOGY OF EXTRACT - IN VITRO	PEROXIDE FORMATION INHIBITION	Cudrania tricuspidata (MORACEAE)
1304859	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cudrania tricuspidata (MORACEAE)	SENEGALENSIN
926940	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cudrania tricuspidata (MORACEAE)	ERYTHRININ C
728952	PHARMACOLOGY OF EXTRACT - IN VITRO	PEROXIDE FORMATION INHIBITION	Cudrania tricuspidata (MORACEAE)
114466	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cudrania tricuspidata (MORACEAE)	CUDRAXANTHONE H
561371	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Cudrania tricuspidata (MORACEAE)
561382	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Cudrania tricuspidata (MORACEAE)
236316	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)	GERICUDRANIN C
728956	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIOXIDANT ACTIVITY	Cudrania tricuspidata (MORACEAE)
236312	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cudrania tricuspidata (MORACEAE)	GERICUDRANIN C
122933	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Cudrania tricuspidata (MORACEAE)	CUDRAXANTHONE L
561375	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Cudrania tricuspidata (MORACEAE)
124595	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORTLC DATA REPORTED		Cudrania tricuspidata (MORACEAE)	CUDRAXANTHONE G
1304853	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Cudrania tricuspidata (MORACEAE)	FLAVONE,ISO: 5-4-DIHYDROXY-6-(3'-METHYLBUT-2"-ENYL)-2"-(4"-HYDROXY-4"METYLETHYL)-3"-METHOXYDIHYDROFURANO-[4',5",7,8]:
1274417	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cudrania tricuspidata (MORACEAE)	XANTHEN-9-ONE,9(H): 2-3-6-8-TETRAHYDROXY-1-(3-METHYL-BUT-2-ENYL)-5-(2-METHYL-BUT-3-EN-2-YL):
181257	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)	GERICUDRANIN D
181256	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)	GERICUDRANIN D
236301	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)	GERICUDRANIN A
1304869	PHARMACOLOGY OF COMPOUND - IN VITRO	NITRIC OXIDE RELEASE INHIBITION	Cudrania tricuspidata (MORACEAE)	OROBOL
747130	PHARMACOLOGY OF EXTRACT - IN VITRO	ALDOSE REDUCTASE INHIBITION	Cudrania tricuspidata (MORACEAE)
728945	PHARMACOLOGY OF EXTRACT - IN VITRO	RADICAL SCAVENGING EFFECT	Cudrania tricuspidata (MORACEAE)
112045	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORTLC DATA REPORTED		Cudrania tricuspidata (MORACEAE)	CUDRAXANTHONE G
236309	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)	GERICUDRANIN B
1057795	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cudrania tricuspidata (MORACEAE)	CUDRAXANTHONE D
1274420	X-RAY CHRYSTALLOGRAPHIC STUDIESQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cudrania tricuspidata (MORACEAE)	CUDRAXANTHONE L
1304866	PHARMACOLOGY OF COMPOUND - IN VITRO	NITRIC OXIDE RELEASE INHIBITION	Cudrania tricuspidata (MORACEAE)	ERYSENEGALENSEIN E
926944	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cudrania tricuspidata (MORACEAE)	CUDRAFLAVONE B
181263	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)	CERICUDRANIN E
821814	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Cudrania tricuspidata (MORACEAE)	CUDRAFLAVONE B
112043	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORTLC DATA REPORTED		Cudrania tricuspidata (MORACEAE)	CUDRAXANTHONE E
114469	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cudrania tricuspidata (MORACEAE)	CUDRAXANTHONE K
728949	PHARMACOLOGY OF EXTRACT - IN VITRO	PEROXIDE FORMATION INHIBITION	Cudrania tricuspidata (MORACEAE)
236305	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)	GERICUDRANIN A
395482	MEDICINAL FOLKLORE REPORTED FOR	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Cudrania tricuspidata (MORACEAE)
1304863	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cudrania tricuspidata (MORACEAE)	GERICUDRANIN E
1304856	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cudrania tricuspidata (MORACEAE)	FLAVONE,ISO: 3-5-DIHYDROXY-4-METHOXY-2',2'-DIMETHYPYRANO-(5',6',6,7):
561378	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Cudrania tricuspidata (MORACEAE)
925802	VOUCHER SPECIMEN REPORTED FOR		Cudrania tricuspidata (MORACEAE)
181260	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cudrania tricuspidata (MORACEAE)	CERICUDRANIN E
738115	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)
561381	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Cudrania tricuspidata (MORACEAE)
236302	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)	GERICUDRANIN A
1304849	MEDICINAL FOLKLORE REPORTED FOR	ANTIBACTERIAL ACTIVITY	Cudrania tricuspidata (MORACEAE)
821813	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Cudrania tricuspidata (MORACEAE)	CUDRAFLAVONE A
925803	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHYPERCHOLESTEROLEMIC ACTIVITY	Cudrania tricuspidata (MORACEAE)
561387	PHARMACOLOGY OF COMPOUND - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Cudrania tricuspidata (MORACEAE)	KAEMPFEROL
728955	PHARMACOLOGY OF EXTRACT - IN VITRO	PEROXIDE FORMATION INHIBITION	Cudrania tricuspidata (MORACEAE)
124593	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORTLC DATA REPORTED		Cudrania tricuspidata (MORACEAE)	CUDRAXANTHONE F
236313	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)	GERICUDRANIN C
820766	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)	Cudrania tricuspidata (MORACEAE)
236315	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)	GERICUDRANIN C
561376	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Cudrania tricuspidata (MORACEAE)
181255	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)	GERICUDRANIN D
820767	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)	Cudrania tricuspidata (MORACEAE)
738117	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)
561370	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Cudrania tricuspidata (MORACEAE)
124596	CMR SPECTRUM REPORTEDTLC DATA REPORTEDISOLATION AND IDENTIFICATION OF		Cudrania tricuspidata (MORACEAE)	JACAREUBIN,ISO: 6-DEOXY:
112044	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORTLC DATA REPORTED		Cudrania tricuspidata (MORACEAE)	CUDRAXANTHONE F
1304852	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Cudrania tricuspidata (MORACEAE)	FLAVONE,ISO: 5-7-DIHYDROXY-6-(2'-HYDROXY-3'-METHYLBUT-3"-ENYL)-4'-METHOXY:
1034778	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cudrania tricuspidata (MORACEAE)	CUDRAXANTHONE A
1189569	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMUTAGENIC ACTIVITY	Cudrania tricuspidata (MORACEAE)
181262	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)	CERICUDRANIN E
751435	PHARMACOLOGY OF EXTRACT - IN VITRO	PROTEIN EXPRESSION INHIBITION	Cudrania tricuspidata (MORACEAE)
728950	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIOXIDANT ACTIVITY	Cudrania tricuspidata (MORACEAE)
774699	PHARMACOLOGY OF EXTRACT - IN VIVO	NITRIC OXIDE SUPPRESSION	Cudrania tricuspidata (MORACEAE)
1189570	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMUTAGENIC ACTIVITY	Cudrania tricuspidata (MORACEAE)
1304855	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Cudrania tricuspidata (MORACEAE)	FLAVONOL,4'-5-7-TRIHYDROXY-8-PARAHYDROXYBENZYL-DIHYDRO:
926945	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cudrania tricuspidata (MORACEAE)	UMBELLIFERONE
122930	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cudrania tricuspidata (MORACEAE)	CUDRAXANTHONE N
236308	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)	GERICUDRANIN B
738118	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)
738120	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)
561386	ISOLATION AND IDENTIFICATION OF		Cudrania tricuspidata (MORACEAE)	ARTHOCARPESINKAEMPFEROLARTHOCARPETIN,NOR:POPULNIN
1057794	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cudrania tricuspidata (MORACEAE)	CUDRAXANTHONE C
751433	PHARMACOLOGY OF EXTRACT - IN VITRO	NITRIC OXIDE SYNTHESIS INHIBITION	Cudrania tricuspidata (MORACEAE)
1304862	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cudrania tricuspidata (MORACEAE)	OROBOL
84555	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cudrania tricuspidata (MORACEAE)	QUERCIMERITRIN
561379	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Cudrania tricuspidata (MORACEAE)
236304	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)	GERICUDRANIN A
181265	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)	CERICUDRANIN E
926942	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cudrania tricuspidata (MORACEAE)	KAEMPFEROL,2-3-DIHYDRO:
1304871	PHARMACOLOGY OF COMPOUND - IN VITRO	NITRIC OXIDE RELEASE INHIBITION	Cudrania tricuspidata (MORACEAE)	FLAVONOL,4'-5-7-TRIHYDROXY-8-PARAHYDROXYBENZYL-DIHYDRO:SENEGALENSINGERICUDRANIN DFLAVONE,ISO: 3-5-DIHYDROXY-4-METHOXY-2',2'-DIMETHYPYRANO-(5',6',6,7):FLAVONE,ISO: 5-7-DIHYDROXY-6-(2'-HYDROXY-3'-METHYLBUT-3"-ENYL)-4'-METHOXY:
597923	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Cudrania tricuspidata (MORACEAE)	KAEMPFEROLPOPULNIN
490486	PHARMACOLOGY OF EXTRACT - IN VITRO	TRYPSIN INHIBITION	Cudrania tricuspidata (MORACEAE)
1034780	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cudrania tricuspidata (MORACEAE)	CUDRAXANTHONE C
774700	PHARMACOLOGY OF EXTRACT - IN VIVO	RENAL FUNCTION IMPROVEMENT	Cudrania tricuspidata (MORACEAE)
738116	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)
390149	ISOLATION AND IDENTIFICATION OF		Cudrania tricuspidata (MORACEAE)	MUMENINPRUNIN
1304857	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cudrania tricuspidata (MORACEAE)	ERYSENEGALENSEIN E
1304865	PHARMACOLOGY OF COMPOUND - IN VITRO	NITRIC OXIDE RELEASE INHIBITION	Cudrania tricuspidata (MORACEAE)	FLAVONE,ISO: 5-4-DIHYDROXY-6-(3'-METHYLBUT-2"-ENYL)-2"-(4"-HYDROXY-4"METYLETHYL)-3"-METHOXYDIHYDROFURANO-[4',5",7,8]:
181254	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cudrania tricuspidata (MORACEAE)	GERICUDRANIN D
820768	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)	Cudrania tricuspidata (MORACEAE)
926946	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cudrania tricuspidata (MORACEAE)	CUDRAFLAVONE D
728954	PHARMACOLOGY OF EXTRACT - IN VITRO	RADICAL SCAVENGING EFFECT	Cudrania tricuspidata (MORACEAE)
728948	PHARMACOLOGY OF EXTRACT - IN VITRO	RADICAL SCAVENGING EFFECT	Cudrania tricuspidata (MORACEAE)
181258	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)	GERICUDRANIN D
122931	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cudrania tricuspidata (MORACEAE)	CUDRAXANTHONE O
236307	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)	GERICUDRANIN B
1304851	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FOR	NITRIC OXIDE RELEASE INHIBITION	Cudrania tricuspidata (MORACEAE)
561380	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Cudrania tricuspidata (MORACEAE)
747131	PHARMACOLOGY OF EXTRACT - IN VITRO	ALDOSE REDUCTASE INHIBITION	Cudrania tricuspidata (MORACEAE)
84553	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cudrania tricuspidata (MORACEAE)	CYCLOARTOCARPESIN
738121	PHARMACOLOGY OF EXTRACT - IN VITRO	APOPTOSIS INDUCTION	Cudrania tricuspidata (MORACEAE)
561374	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Cudrania tricuspidata (MORACEAE)
1034779	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cudrania tricuspidata (MORACEAE)	CUDRAXANTHONE B
561385	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Cudrania tricuspidata (MORACEAE)
1304854	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Cudrania tricuspidata (MORACEAE)	FLAVONE,ISO: 5-4-DIHYDROXY-6-(3'-METHYLBUT-2"-ENYL)-2"-(4"-HYDROXY-4"METYLETHYL)-3"-METHOXYDIHYDROFURANO-[4',5",7,8]:
1055031	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cudrania tricuspidata (MORACEAE)	CUDRAFLAVANONE A
181261	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)	CERICUDRANIN E
926941	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cudrania tricuspidata (MORACEAE)	CYCLOARTOCARPESIN
236310	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Cudrania tricuspidata (MORACEAE)	GERICUDRANIN B
84554	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cudrania tricuspidata (MORACEAE)	POPULNIN
1057793	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Cudrania tricuspidata (MORACEAE)	CUDRAXANTHONE B
751434	PHARMACOLOGY OF EXTRACT - IN VITRO	NITRIC OXIDE SYNTHASE INHIBITION	Cudrania tricuspidata (MORACEAE)
728951	PHARMACOLOGY OF EXTRACT - IN VITRO	RADICAL SCAVENGING EFFECT	Cudrania tricuspidata (MORACEAE)
1274419	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Cudrania tricuspidata (MORACEAE)	MACLURAXANTHONE B
1304861	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cudrania tricuspidata (MORACEAE)	FLAVONE,ISO: 4'-5-7-TRIHYDROXY-6,8-PRENYL:
747128	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Cudrania tricuspidata (MORACEAE)

Experiments for taxon Cudrania tricuspidata (MORACEAE)

Experiments (166 results)

Filters

Worktypes (23)

Pharmacology (23)

Compounds (54)

Organisms (40)